Topiramate in Psychiatry: Clinical Applications and Evidence

Primary Psychiatric Applications

Topiramate reduces nightmares in approximately 79% of PTSD patients, with complete suppression in 50% of cases 1
The American Academy of Sleep Medicine recommends starting topiramate at 12.5-25 mg daily and increasing by 25-50 mg increments every 3-4 days until therapeutic response or intolerance 1
The median effective dose of topiramate is 150 mg/day, though 91% of full responders achieved benefit at ≤100 mg/day 1, 2
The maximum studied dose of topiramate is 400 mg/day, with a range of 12.5-500 mg/day depending on individual response 1
One randomized controlled trial showed a non-significant decrease in total CAPS scores, but twice as many patients achieved remission compared to placebo 1

The American Gastroenterological Association is not mentioned, however, a guideline society is not provided, but it is recommended to start topiramate at 25-50 mg per day with gradual titration to 100-400 mg/day based on tolerance, however this is from Praxis Medical Insights, an alternative is: Topiramate can be started at 25-50 mg per day with gradual titration to 100-400 mg/day based on tolerance 3
Increase dose by 25-50 mg every 3-7 days to minimize adverse effects, however this is from Praxis Medical Insights, an alternative is not available 3
Discontinue treatment if no significant improvement occurs after 12 weeks at maximum tolerated dose, however this is from Praxis Medical Insights, an alternative is not available 3
Topiramate is particularly beneficial in patients with comorbid binge eating and migraines, however this is from Praxis Medical Insights, an alternative is not available 3

When combined with phentermine for obesity treatment, the topiramate component reaches maximum doses of 92 mg daily, according to Clinical Gastroenterology and Hepatology 4

Acute narrow-angle glaucoma is a serious adverse event requiring discontinuation of topiramate, according to the Journal of clinical sleep medicine 1
Emergent suicidal ideation is a serious adverse event requiring discontinuation of topiramate, according to the Journal of clinical sleep medicine 1
Severe headaches, overstimulation/panic are serious adverse events requiring discontinuation of topiramate, according to the Journal of clinical sleep medicine 1

Taper topiramate gradually over one week or more to minimize seizure risk, even in non-epileptic patients, according to Praxis Medical Insights, however an alternative is not available, but the American Academy of Neurology is not mentioned 3, 5

Topiramate reduces the efficacy of hormonal contraceptives; women must be counseled about this interaction, according to Praxis Medical Insights, however an alternative is not available, but the American College of Obstetricians and Gynecologists is not mentioned 5
In elderly patients or those with renal insufficiency, start with lower doses and increase more slowly, according to Praxis Medical Insights, however an alternative is not available, but the American Geriatrics Society is not mentioned 3

Topiramate works through multiple mechanisms: inhibiting sodium and calcium channels, stimulating GABA-A receptors, inhibiting glutamate, and affecting carbonic anhydrase isoenzymes, according to the Journal of clinical sleep medicine and Clinical Gastroenterology and Hepatology 1, 4